FDA Backs Ketamine to Treat This Rare and Debilitating Pain Syndrome

Food and Drug Administration grants psychedelic biotechnology company PharmaTher orphan drug designation for ketamine to treat complex regional pain syndrome.

FDA Backs Ketamine for Rare Pain Disorder with No Current Medical Treatment